Supreme Court Flags Generic-Only Prescriptions and Pharma Freebies: What the Dolo-650 Case Reveals
Introduction A recent hearing before the Supreme Court of India in W.P.(C) No. 323/2021 (FMRAI v. Union of India) has brought renewed focus on two systemic issues in India’s pharmaceutical ecosystem: These proceedings indicate that stronger statutory reforms may soon reshape the … Read more